← Back to all recalls
DRUG RECALLMODERATE
Kirkland Signature Ultra Strength Antacid
Kirkland Signature antacid recalled due to metallic particles in tablets.
What to do
Stop using the recalled antacid tablets and return them to Costco for a refund or contact Guardian Drug Company for further instructions.
Why it was recalled
Guardian Drug Company is recalling Kirkland Signature Ultra Strength Antacid chewable tablets, 1000 mg, 265-count bottles, due to the presence of small metallic particles in the tablets.
Is mine affected?
This recall covers 23 products. Check the NDC or UPC and strength printed on the package. Yours is affected if it matches one below.
| Product | Lot code | Strength | NDC / UPC | Recall # |
|---|---|---|---|---|
| HyVee, Ultra Strength Antacid, Calcium Carbonate | 1716089, 2029 | 1000 mg | UPC 0 75450 82514 5 | D-0572-2026 |
| HALEON CALCIUM CARBONATE TUMS ANTACID, Assorted Fruit Tablets | 1096075, 1096076, 1096077, 1096078, 2029 | 1000 mg | UPC 3 07660 74610 2 | D-0558-2026 |
| CAREone, EXTRA STRENGTH CALCIUM ANTACID, Calcium Carbonate | 1276118, 1276119, 2029 | 750 mg | NDC 72476-127-80 | D-0565-2026 |
| HyVee, Extra Strength Antacid, Calcium Carbonate | 1276119, 2029 | 750 mg | UPC 0 75450 82497 1 | D-0571-2026 |
| TopCare health, ULTRA STRENGTH, Antacid Tablets, CALCIUM CARBONATE | 1716089, 2029 | 1000 mg | NDC 76162-129-68 | D-0579-2026 |
| GOODSENSE Ultra Strength, Antacid TABLETS, Calcium Carbonate | 1716089, 2029 | 1000 mg | NDC 50804-171-68 | D-0575-2026 |
| DISCOUNT drug mart, EXTRA STRENGTH, ANTACID TABLETS, Calcium Carbonate | 1276118, 2029 | 750 mg | UPC 0 93351 03992 8 | D-0567-2026 |
| Extra strength Antacid Calcium Carbonate | 1276118, 2029 | 750 mg | UPC 0 98437 24361 9 | D-0562-2026 |
Show all 23 products
| Product | Lot code | Strength | NDC / UPC | Recall # |
|---|---|---|---|---|
| HALEON CALCIUM CARBONATE TUMS ANTACID, Assorted Fruit Tablets | 1076169, 2029 | 750 mg | UPC 3 0766 3072 10 9 | D-0559-2026 |
| EQUALINE extra strength, antacid tablets, calcium carbonate | 1276118, 2029 | 750 mg | NDC 41163-129-22 | D-0576-2026 |
| CAREone, ULTRA STRENGTH CALCIUM ANTACID, Calcium Carbonate | 1716259, 2029 | 1000 mg | NDC 72476-178-23 | D-0566-2026 |
| EQUALINE ultra strength, antacid tablets, calcium carbonate | 1716089, 2029 | 1000 mg | NDC 41163-171-68 | D-0577-2026 |
| GOODSENSE Extra Strength, Antacid TABLETS, Calcium Carbonate | 1276118, 2029 | 750 mg | NDC 50804-129-22 | D-0574-2026 |
| Good Neighbor Pharmacy, extra strength Antacid Calcium Carbonate | 1716089, 2029 | 1000 mg | NDC 24385-595-23 | D-0561-2026 |
| MARKET BASKET ANTACID Calcium Carbonate | 1716089, 2029 | 1000 mg | UPC 0 49705 83149 6 | D-0564-2026 |
| FAMILY WELLNESS, ULTRA STRENGT, ANTACID TABLETS, Calcium Carbonate | 1716089, 2029 | 1000 mg | NDC 55319-171-68 | D-0568-2026 |
| H.E.B Extra Strength Calcium Carbonate Antacid Tablets, Calcium Carbonate | 1276118, 2029 | 750 mg | NDC 37808-136-22 | D-0573-2026 |
| TopCare health, EXTRA STRENGTH, Antacid Tablets, CALCIUM CARBONATE | 1276119, 2029 | 750 mg | NDC 76162-128-22 | D-0578-2026 |
| 24/7 life BY 7-ELEVEN, Extra strength Antacid Tablets, Calcium Carbonate | 1276119, 2029 | 750 mg | UPC 0 5254863573 2 | D-0563-2026 |
| Good Neighbor Pharmacy, extra strength Antacid Calcium Carbonate | 1276118, 2029 | 750 mg | NDC 24385-106-80 | D-0560-2026 |
| Harris Teeter, ULTRA STRENGTH ANTACID, Calcium Carbonate | 1716089, 2029 | 1000 mg | UPC 0 72036-73108-1 | D-0570-2026 |
| KIRKLAND Signature, ULTRA STRENGTH ANTACID, Calcium Carbonate | 1716059, 1716060, 1716061, 1716062, 1716063, 1716218, 1716219, 1716228, 1716229, 1716238, 2029 | 1000 mg | NDC 63981-171-80 | D-0557-2026 |
| FAMILY WELLNESS, ULTRA STRENGT, ANTACID TABLETS, Calcium Carbonate | 1716259, 2029 | 1000 mg | UPC 0 32251-92282-4 | D-0569-2026 |
Where it was sold
Distributed nationwide.
Timeline
- Firm initiated recall
- Publicly announced
- Listed on Recall Canary
- Summary updated
Official source
← Back to all recalls
Editorial summary by Recall Canary · summary updated 2026-09-03 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification